Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

FHS
July 24, 2023
9:09 am

Cutting-edge research at the Luxembourg Institute of Health reveals the ground-breaking therapeutic potential of the compound FL3 in inhibiting oncogene translation and rewiring cancer cell metabolism, opening up new therapeutic opportunities for leukemia patients.

Highly-awaited PhIII study of Gates-backed tuberculosis vaccine underway

A large study of an experimental vaccine for the world’s biggest infectious disease has finally kicked off in South Africa. The Bill & Melinda Gates

March 20, 2024

Study: Drug-involved overdose deaths increased by over 500% in 2022

Drug-involved overdose deaths increased by over 500 percent in 2022 according to a study at Columbia University Mailman School of Public Health, with trends attributed

August 5, 2024

Oral health strategies for healthy aging: A call to action

Research explores the connection between aging populations and oral health, proposing an integrated model to address health challenges in older adults, with a focus on

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.